Condensed Consolidated Balance Sheets (unaudited) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets
Cash	$ 31,403,174	$ 51,100,915
Accounts receivable, net	9,158,909	5,285,321
Related party receivables	5,909	366,590
Inventories, net	50,424,216	41,012,124
Prepaid expenses and other current assets	4,184,583	3,494,473
Total current assets	95,176,791	101,259,423
Restricted Cash	4,900,000	4,900,000
Property and equipment, net	30,862,978	27,030,400
Operating lease right-of-use assets	17,037,892	17,836,756
Finance right-of-use asset	783,075	883,076
Intangible assets, net	16,742,424	6,592,316
Goodwill	16,541,041	14,440,683
Investments	1,400,000	400,000
Equity-method investments	963,685	963,685
Other assets	1,267,885	993,538
Total assets	185,675,771	175,299,877
Current Liabilities
Accounts payable	18,042,286	16,889,756
Accrued payroll	3,629,110	2,526,917
Other accrued expenses	1,477,320	1,144,573
Related party payable	975,344	1,634,775
Current portion of operating lease liability	2,037,520	2,633,236
Current portion of finance lease liability	403,824	413,487
Current portion of long-term debt	501,453	494,173
Total current liabilities	27,066,857	25,736,917
Long-term Liabilities
Revolving line of credit	0	0
Operating lease liability, net of current portion	27,317,015	27,605,739
Finance lease liability, net of current portion	398,578	482,544
Long-term debt, net of current portion	955,505	1,083,634
Warrant liability	2,124,485	2,058,566
Total liabilities	57,862,440	56,967,400
Commitments and Contingencies (Notes 11 and 16)
Stockholders' Deficit
Additional paid-in capital	252,395,590	250,163,984
Accumulated deficit	(127,178,957)	(132,158,016)
Accumulated other comprehensive loss	(65,545)	0
Total stockholders' equity (deficit)—Thorne HealthTech, Inc.	125,678,376	118,531,510
Non-controlling interest	2,134,955	(199,033)
Total stockholders' equity	127,813,331	118,332,477
Total liabilities, convertible preferred stock and stockholders' equity	185,675,771	175,299,877
Series E Preferred Stock [Member]
Long-term Liabilities
Series E convertible preferred stock; par value $0.01, 0 shares authorized as of March 31, 2022 and December 31, 2021; 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021	0	0
Common Class B [Member]
Stockholders' Deficit
Common Stock, Value, Issued	0	0
Common Class Undefined [Member]
Stockholders' Deficit
Common Stock, Value, Issued	$ 527,288	$ 525,542